Groundbreaking new research from TMU is showing remarkable success in using AI tools to assess and interpret breast cancer tissue, particularly focusing on the Ki-67 biomarker.聽
The TMU team developed a custom AI tool that helps pathologists make more consistent and reliable treatment decisions which can revolutionize cancer care. The research is led by professor April Khademi, Canada Research Chair and medical image analysis expert with support from PhD student Amanda Dy.聽
鈥淭his research represents a significant milestone in the integration of AI technologies into pathology workflows,鈥 said Khademi, a biomedical engineer who was named Canada Research Chair in AI for Medical Imaging this year. 鈥淔indings suggest that AI tools not only improve assessment accuracy which results in more reliable treatment options, but also offer a substantial return on investment by streamlining workflow and enhancing patient care."
The Ki-67 biomarker, identified as a crucial indicator for has traditionally posed challenges for pathologists - in that there is a high level of disagreement on how to score the tissue. This impedes the pathologists鈥 ability to deliver accurate and efficient .
Khademi鈥檚 pioneering research has been supported by a consortium of leading organizations including the (CCS) and the has propelled the field forward.
The AI-powered tool was rigorously tested and out-performed . This tool was tested live in an innovative study with 90 international pathologists and showed AI assistance significantly enhanced pathologists' assessments, leading to more accurate and efficient scoring of the Ki67 biomarker. Most notably, the AI tool improved pathologist scoring accuracy, agreement and turn-around-time.聽
鈥淚t's fundamental for engineers to collaborate and seek feedback from clinicians when designing and evaluating AI tools for clinical decision support,鈥 said Dy. 鈥淭his allows us to refine our work based on expert feedback while clinicians can grow more confident in the AI outputs,鈥 adding that the key to growing confidence and trust in AI within the medical community lies in transparency and interdisciplinary collaboration.
